CVS 2012 Annual Report Download - page 16

Download and view the complete annual report

Please find page 16 of the 2012 CVS annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 92

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92

We’re a leader in the
rapidly growing specialty
pharmacy market.
Our innovative solutions cover the entire
continuum of specialty pharmacy care.
The current pipeline for new prescription drugs is dominated by specialty medications. By 2016, roughly one-third of
all pharmacy spending in the United States will be for high-cost specialty medications, presenting significant challenges
for payors. Roughly half of specialty spending will be covered by pharmacy benefits while the other half will be covered
under the medical benefit. We are developing capabilities that manage spending for payors across the entire continuum
of specialty care, and we are poised to capture an even larger share of this rapidly growing market. Our suite of solutions
is focused on three key areas, namely minimizing drug costs, addressing inappropriate utilization, and ensuring that
the lowest cost, clinically effective products are chosen. The integrated specialty initiative we are currently piloting
represents another key point of differentiation in the marketplace. It offers the clinical support of traditional specialty
pharmacy with the convenience of retail access. Through this initiative, specialty patients will have the choice of sending
in their prescriptions by mail or simply dropping them off at any of our more than 7,400 retail locations. They can also
decide whether to pick up their medication at the store or have it mailed to their home. This new capability significantly
improves access and the patient experience, and no other PBM is able to offer this level of service and flexibility.
14
CVS CAREMARK 2012 ANNUAL REPORT